These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum). Subramaniam S; Snyder SH Neuropharmacology; 2011 Jun; 60(7-8):1187-92. PubMed ID: 21044641 [TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease. Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156 [TBL] [Abstract][Full Text] [Related]
6. Global Rhes knockout in the Q175 Huntington's disease mouse model. Heikkinen T; Bragge T; Kuosmanen J; Parkkari T; Gustafsson S; Kwan M; Beltran J; Ghavami A; Subramaniam S; Shahani N; Ramírez-Jarquín UN; Park L; Muñoz-Sanjuán I; Marchionini DM PLoS One; 2021; 16(10):e0258486. PubMed ID: 34648564 [TBL] [Abstract][Full Text] [Related]
7. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. Mealer RG; Murray AJ; Shahani N; Subramaniam S; Snyder SH J Biol Chem; 2014 Feb; 289(6):3547-54. PubMed ID: 24324270 [TBL] [Abstract][Full Text] [Related]
9. MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation. Fawal MA; Brandt M; Djouder N Dev Cell; 2015 Apr; 33(1):67-81. PubMed ID: 25816988 [TBL] [Abstract][Full Text] [Related]
10. Structure-guided mutation of the conserved G3-box glycine in Rheb generates a constitutively activated regulator of mammalian target of rapamycin (mTOR). Mazhab-Jafari MT; Marshall CB; Ho J; Ishiyama N; Stambolic V; Ikura M J Biol Chem; 2014 May; 289(18):12195-201. PubMed ID: 24648513 [TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia. Brugnoli A; Napolitano F; Usiello A; Morari M Neurobiol Dis; 2016 Jan; 85():155-163. PubMed ID: 26522958 [TBL] [Abstract][Full Text] [Related]
12. The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes. Harrison LM; Lahoste GJ Exp Cell Res; 2013 Sep; 319(15):2310-5. PubMed ID: 23583659 [TBL] [Abstract][Full Text] [Related]
13. Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route. Subramaniam S J Huntingtons Dis; 2022; 11(3):281-290. PubMed ID: 35871361 [TBL] [Abstract][Full Text] [Related]
14. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype. Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255 [TBL] [Abstract][Full Text] [Related]
15. Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment. Angarola B; Ferguson SM Mol Biol Cell; 2019 Oct; 30(22):2750-2760. PubMed ID: 31532697 [TBL] [Abstract][Full Text] [Related]
16. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. Jiang L; Xu L; Mao J; Li J; Fang L; Zhou Y; Liu W; He W; Zhao AZ; Yang J; Dai C J Am Soc Nephrol; 2013 Jun; 24(7):1114-26. PubMed ID: 23661807 [TBL] [Abstract][Full Text] [Related]
17. Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice. Wang X; Li M; Gao Y; Gao J; Yang W; Liang H; Ji Q; Li Y; Liu H; Huang J; Cheng T; Yuan W Exp Cell Res; 2016 Jun; 344(2):219-28. PubMed ID: 27163399 [TBL] [Abstract][Full Text] [Related]
18. Cardiac mTORC1 Dysregulation Impacts Stress Adaptation and Survival in Huntington's Disease. Child DD; Lee JH; Pascua CJ; Chen YH; Mas Monteys A; Davidson BL Cell Rep; 2018 Apr; 23(4):1020-1033. PubMed ID: 29694882 [TBL] [Abstract][Full Text] [Related]